ArticleCEN case reports2026
Congophilic fibrillary glomerulonephritis recurrence post-renal transplant: diagnostic challenges and proteomic insights.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathological diagnosis and differential considerations of renal diseases with organized deposits under an electron microscope: key points in diagnosis.Clinical and experimental nephrology · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fibrillary glomerulonephritis (FGN) is a rare kidney disease characterized by the deposition of Congo red (CR) negative fibrils measuring 12 to 24 nm in diameter on electron microscopy. Recently, DnaJ heat shock protein family (Hsp40) member B9 (DNAJB9) detected by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was discovered to be a sensitive and specific biomarker for FGN. This report presents the first documented case of recurrent congophilic FGN, a rare glomerular disease with features resembling amyloidosis, occurring two years and eight months after a renal transplant. Diagnosis of both primary and recurrent FGN was confirmed through DNAJB9 detection using advanced laser microdissection and LC-MS/MS techniques. The recurrent FGN exhibited features consistent with amyloidosis, including CR positivity, characteristic microscopic findings, and fibrils on electron microscopy with a 9 to 15 nm diameter. This case demonstrates that FGN could recur in the transplanted kidney as congophilic GN with characteristic findings of amyloidosis, and it is difficult, if not impossible, to render a correct diagnosis without LC-MS/MS or immunohistochemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.